Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Companion Animal Pharmaceuticals Market Research Report (2021 to 2026) - by Indication, Animal Type, Distribution Channel, and Region -

December 17, 2021 GMT

DUBLIN--(BUSINESS WIRE)--Dec 17, 2021--

The “Companion Animal Pharmaceuticals Market Research Report by Indication, Animal Type, Distribution Channel, and Region - Global Forecast to 2026 - Cumulative Impact of COVID-19” report has been added to’s offering.

The Global Companion Animal Pharmaceuticals Market size was estimated at USD 11.26 billion in 2020, is expected to reach USD 12.29 billion in 2021, and projected to grow at a CAGR of 9.50% reaching USD 19.42 billion by 2026.


Competitive Strategic Window

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Companion Animal Pharmaceuticals Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Companion Animal Pharmaceuticals Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Companion Animal Pharmaceuticals Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Companion Animal Pharmaceuticals Market?

4. What is the competitive strategic window for opportunities in the Global Companion Animal Pharmaceuticals Market?

5. What are the technology trends and regulatory frameworks in the Global Companion Animal Pharmaceuticals Market?

6. What is the market share of the leading vendors in the Global Companion Animal Pharmaceuticals Market?

7. What modes and strategic moves are considered suitable for entering the Global Companion Animal Pharmaceuticals Market?

Market Dynamics


  • Increasing prevalence of zoonotic diseases
  • Rising availability and adoption of pet health insurance
  • Rising initiatives by government and private organisation to promote animal health


  • High storage cost for vaccines


  • Rising development of new drugs
  • Growing investment by key players


  • Stringent regulations associated with the approval for drugs

Companies Mentioned

  • Ashish Life Science Pvt. Ltd.
  • Boehringer Ingelheim GmbH
  • Ceva Sante Animale
  • Chanelle Pharma
  • Dechra Pharmaceuticals plc
  • Eco Animal Health Group plc
  • Elanco Animal Health Incorporated
  • Endovac Animal Health
  • Hipra
  • Indian Immunologicals Ltd.
  • Inovet
  • Kyoritsu Seiyaku
  • Lutim Pharma Pvt. Ltd.
  • Merck & Co. Inc.
  • Norbrook Holdings Limited
  • Tianjin Ringpu Bio-Technology Co. Ltd.
  • Vetoquinol S.A.
  • Virbac
  • Zoetis Inc.
  • Zydus Animal Health and Investments Limited

For more information about this report visit

View source version on


Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900



SOURCE: Research and Markets

Copyright Business Wire 2021.

PUB: 12/17/2021 10:13 AM/DISC: 12/17/2021 10:13 AM